Market Research Logo

Global Osteoporosis Market, Patients, Companies & Forecast

Global Osteoporosis Market, Patients, Companies & Forecast

Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.

This is the 2nd edition report on Osteoporosis by Renub Research. Report titled “Global Osteoporosis Market, Patients, Companies & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points:

1) Osteoporosis Patients & Forecast
2) Hip fracture Patients & Forecast
3) Osteoporosis Market & Forecast
4) Country Wise Osteoporosis level of Awareness, Guidelines & Policy
5) Country Wise Reimbursement of Medication
6) Company Wise Osteoporosis Drugs Sales & Forecast

All the 10 Countries studied in the report are as follows

1) India
2) China
3) Japan
4) Korea
5) Brazil
6) Russia
7) United Kingdom
8) France
9) Germany
10) United States

Worldwide Osteoporosis – Company Wise Drugs Sales Analysis (2010 – 2019)

1) Merck
2) Sanofi
3) Novartis
4) Eli Lilly
5) Amgen

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.


  • Executive Summary
  • Worldwide Osteoporosis Patients Population Analysis
    • Worldwide Osteoporosis Patients Population (2010 - 2019)
    • Worldwide Hip Fracture Patients Population (2010 - 2019)
  • Worldwide Osteoporosis Market (2010 - 2019)
  • Worldwide Osteoporosis Share Analysis
    • Worldwide Osteoporosis Patients Population Share (2010 - 2019)
    • Worldwide Hip Fracture Patients Population Share (2010 - 2019)
    • Worldwide Osteoporosis Market Share (2010 - 2019)
    • Worldwide Osteoporosis Drugs Company Market Share (2010 - 2019)
  • India
    • India Osteoporosis Patients Population (2010 - 2019)
    • India Hip Fracture Patients Population (2010 - 2019)
    • India Osteoporosis Market (2010 - 2019)
    • Level of Awareness
    • Fracture Registries
    • Government Policies
    • Guidelines
    • Reimbursement of Medication
      • Table India - Osteoporosis Treatments & Respective Reimbursement Status, 2013
  • China
    • China Osteoporosis Patients Population (2010 - 2019)
    • China Hip Fracture Patients Population (2010 - 2019)
    • China Osteoporosis Market (2010 - 2019)
    • Level of Awareness
    • Fracture Registries
    • Government Policies
    • Guidelines
    • Reimbursement of Medication
      • Table China - Osteoporosis Treatments & Respective Reimbursement Status, 2013
  • Japan
    • Japan Osteoporosis Patients Population (2010 - 2019)
    • Japan Hip Fracture Patients Population (2010 - 2019)
    • Japan Osteoporosis Market (2010 - 2019)
    • Level of Awareness
    • Fracture Registries
    • Government Policies
    • Guidelines
    • Reimbursement of Medication
      • Table Japan - Osteoporosis Treatments & Respective Reimbursement, 2013
  • Korea
    • Korea Osteoporosis Patients Population (2010 - 2019)
    • Korea Hip Fracture Patients Population (2010 - 2019)
    • Korea Osteoporosis Market (2010 - 2019)
    • Level of Awareness
    • Fracture Registries
    • Government Policies
    • Guidelines
    • Reimbursement of Medication
      • Table Korea - Osteoporosis Treatments & Respective Reimbursement, 2013
  • Brazil
    • Brazil Osteoporosis Patients Population (2010 - 2019)
    • Brazil Hip Fracture Patients Population (2010 - 2019)
    • Brazil Osteoporosis Market (2010 - 2019)
    • Level of Awareness
    • Guidelines & Policy
    • Reimbursement Policy
  • Russia
    • Russia Osteoporosis Patients Population (2010 - 2019)
    • Russia Hip Fracture Patients Population (2010 - 2019)
    • Russia Osteoporosis Market (2010 - 2019)
    • Level of Awareness
    • Government Policy
    • Guidelines
    • Reimbursement
  • United Kingdom
    • United Kingdom Osteoporosis Patients Population (2010 - 2019)
    • United Kingdom Hip Fracture Patients Population (2010 - 2019)
    • United Kingdom Osteoporosis Market (2010 - 2019)
    • Guidelines
    • Reimbursement Policy
      • Table United Kingdom - Available Medical Interventions & Reimbursement Policies, 2013
  • France
    • France Osteoporosis Patients Population (2010 - 2019)
    • France Hip Fracture Patients Population (2010 - 2019)
    • France Osteoporosis Market (2010 - 2019)
    • Guidelines
    • Reimbursement Policy
      • Table France - Available Medical Interventions & Reimbursement Policies, 2013
  • Germany
    • Germany Osteoporosis Patients Population (2010 - 2019)
    • Germany Hip Fracture Patients Population (2010 - 2019)
    • Germany Osteoporosis Market (2010 - 2019)
    • Guidelines
    • Reimbursement Policy
      • Table Germany - Available Medical Interventions & Reimbursement Policies, 2013
  • United States
    • United States Osteoporosis Patients Population (2010 - 2019)
    • United States Hip Fracture Patients Population (2010 - 2019)
    • United States Osteoporosis Market (2010 - 2019)
    • Policy
    • Guidelines
    • Reimbursement Policy
  • Growth Driver
    • Widespread Vitamin D Deficiency & Low Calcium Intake
    • Globally Increasing Ageing Population & Life Expectancy
  • Challenges
    • Lack of Reimbursement / Other Restrictions for Reimbursement
    • Limited Access of Diagnostic Tools & Low Levels of Public and Health Professional Awareness
    • Lack of Government Osteoporosis Policy, Guidelines & National Health Priority in Asia Pacific Countries
      • Table Asia Pacific - Status of Osteoporosis in NHP & Guidelines Availability, 2013
  • Key Players Osteoporosis Drugs Sales & Forecast
    • Merck Osteoporosis Drugs Sales (2010 - 2019)
    • Sanofi Osteoporosis Drugs Sales (2010 - 2019)
    • Novartis Osteoporosis Drugs Sales (2010 - 2019)
    • Eli Lilly Osteoporosis Drugs Sales (2010 - 2019)
    • Amgen Osteoporosis Drugs Sales (2010 - 2019)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report